Agios Pharmaceuticals

a public American pharmaceutical company

AGIO Nasdaq ISIN US00847X1046 SEC CIK 1439222 LEI 529900ONJHY8EOGYT555
Follow Agios Pharmaceuticals Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $55.4M +330% vs same quarter last year
Net income −$65M +37.1% vs same quarter last year
EPS, diluted −$1.09 +38.8% vs same quarter last year
Operating cash flow −$59.2M +32.8% vs same quarter last year
Revenue by quarter
$10.7M
$8.7M
$12.5M
$12.9M
$20M
$20.7M
$44.7M
$55.4M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$1B$0$1B$2BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$54M−$413M
FY24$36.5M$674M
FY23$26.8M−$352M
FY22$14.2M−$232M
FY21$0$1.6B
FY20$0−$327.4M
FY19$117.9M−$411.5M
FY18$94.4M−$346M
FY17$43M−$314.7M
FY16$69.9M−$198.5M
FY15$59.1M−$117.7M
FY14$65.4M−$53.5M
FY13$25.5M−$39.4M
FY12$25.1M−$20.1M
FY11$21.8M−$23.7M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−4000%−2000%0%2000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2588.3%−873.9%−764.4%
FY2488.6%−1166.5%1846.7%
FY2389.3%−1459.5%−1312.3%
FY2288%−2732.1%−1629.2%
FY21---
FY20---
FY1998.9%−268.2%−349%
FY1898.5%−384%−366.6%
FY17100%−745.8%−731.6%
FY16100%−287.6%−284%
FY15-−200.8%−199.1%
FY14-−82.8%−81.9%
FY13-−152.2%−154.2%
FY12-−91.6%−80.1%
FY11-−76.2%−108.6%
Free cash flowOperating cash flow minus capital expenditure
−$600M−$400M−$200M$0$200MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$377.3M
FY24−$391.5M
FY23−$297.1M
FY22−$314.4M
FY21−$413.1M
FY20−$304.9M
FY19−$382.7M
FY18−$311.4M
FY17−$289.9M
FY16$28.6M
FY15−$97.1M
FY14−$61.6M
FY13−$57.7M
FY12−$51M
FY11−$17.1M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Agios Pharmaceuticals
  • Healthcare median
−2000%−1000%0%1000%2000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearAgios PharmaceuticalsHealthcare median
FY25−764.4%−30.6%
FY241846.7%−47%
FY23−1312.3%−58%
FY22−1629.2%−80.4%
FY21-−71.8%
FY20-−62.2%
FY19−349%−46.2%
FY18−366.6%−49.6%
FY17−731.6%−45.9%
FY16−284%−36%
FY15−199.1%−37.8%
FY14−81.9%−35.5%
FY13−154.2%−37.1%
FY12−80.1%−29.1%
FY11−108.6%−27.9%